Retinalamine - instructions for use, analogs, reviews and release forms (injections in ampoules for intramuscular and parabulbar or in the eye injection) of the drug for the treatment of glaucoma, retinal dystrophy in adults, children and pregnancy. Composition

In this article, you can read the instructions for using the drug Retinalamine. There are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors specialists on the use of Retinalamin in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Retinalamin in the presence of existing structural analogues.Use for the treatment of glaucoma, retinal dystrophy, diabetic retinopathy in adults, children, as well as during pregnancy and lactation. Composition of the preparation.

Retinalamine stimulator of tissue repair. Retinalamine - a complex of water-soluble polypeptide fractions with a molecular mass of not more than 10 000 Da.

The drug has a stimulating effect on the photoreceptors and cellular elements of the retina, contributes to the improvement of the functional interaction of the pigment epithelium and the outer segments of the photoreceptors in dystrophic changes, accelerates the restoration of the light sensitivity of the retina. Normalizes vascular permeability, reduces manifestations of local inflammatory reaction, stimulates reparative processes in diseases and traumas of the retina.

The mechanism of action of the drug Retinalamine is determined by its metabolic activity: the drug improves the metabolism of the eye tissues and normalizes the functions of cell membranes, improves intracellular protein synthesis, regulates the processes of lipid peroxidation, promotes the optimization of energy processes.

Composition

Complex of water-soluble polypeptide fractions of the eye retina + auxiliary substances.

Pharmacokinetics

The composition of Retinalamine, the active substance of which is a complex of polypeptide fractions, does not allow the usual pharmacokinetic analysis of its components.

Indications

• compensated primary open-angle glaucoma;
• diabetic retinopathy;
• central retinal dystrophy of inflammatory and traumatic genesis;
• central retinal dystrophy;
• myopic disease (as part of complex therapy);
• central and peripheral taperotorhinal abiotrophy.

Forms of release

Lyophilizate for the preparation of solution for intramuscular and parabulbar (in the eye) administration (injections in ampoules for injection).

Instructions for use and how to use them

Adults with diabetic retinopathy, central retinal dystrophy of inflammatory and traumatic genesis, central and peripheral taperotorinal abiotrophy - parabulbar (in the eye) or intramuscularly 5-10 mg once a day. The course of treatment is 5-10 days; if necessary, repeat after 3-6 months.

With compensated primary open-angle glaucoma - parabulbar or IM in 5 mg once a day. The course of treatment is 10 days; if necessary, repeat after 3-6 months.

When myopic disease - parabulbarno 5 mg once a day. The course of treatment is 10 days. It is recommended in combination with angioprotective and group B vitamins.

The drug is dissolved in 1-2 ml of water for injection, 0.9% solution of sodium chloride or 0.5% solution of procaine (novocain), directing the needle to the wall of the vial to avoid foaming.

Children aged 1-5 years with central retinal dystrophy of inflammatory and traumatic genesis, central and peripheral taperotorhinal abiotrophy - parabulbar or 2.5 mg once a day.

Children aged 6-18 years with central retinal dystrophy of inflammatory and traumatic genesis, central and peripheral taperotorhinal parabulbarno abiotrophy, or 2.5-5 mg once a day.

The drug is dissolved in 1-2 ml of a 0.9% solution of sodium chloride, directing the needle to the wall of the vial to avoid foaming.

The course of treatment is 10 days; if necessary, repeat after 3-6 months.

Side effect

• allergic reactions in case of individual hypersensitivity to the components of the drug.

Contraindications

• age under 18 years - with compensated primary open-angle glaucoma, diabetic retinopathy, myopic disease (due to lack of data on efficacy and safety);
• age up to 1 year - with central retinal dystrophy of inflammatory and traumatic genesis, central and peripheral taperotorhinal abiotrophy;
• individual hypersensitivity to the components of the drug.

Application in pregnancy and lactation

The drug Retinalamine is contraindicated in pregnancy (there is no data on efficacy and safety).

If it is necessary to prescribe the drug during lactation, breastfeeding should be discontinued.

Use in children

Contraindicated at the age of 18 years - with compensated primary open-angle glaucoma, diabetic retinopathy (due to lack of data on efficacy and safety);

Contraindicated at the age of up to 1 year - with central retinal dystrophy of inflammatory and traumatic genesis, central and peripheral taperotorhinal abiotrophy.

special instructions

Retinalamine should be used only as directed by a physician.

The bottle with dissolved medicinal product can not be stored and used after storage.

Solution of the drug Retinalamine is not recommended to be mixed with other solutions.

Features of the drug at the first reception or when it is canceled are absent.

In the case of missed injections, it is not recommended to administer a double dose, but to carry out the next injection as usual on the target day.

Special precautions for the destruction of unused medications are not required.

Impact on the ability to drive vehicles and manage mechanisms

The drug does not affect the ability to drive vehicles and mechanisms.

Drug Interactions

Drug interaction of the drug Retinalamine is not described.

Analogues of the drug Retinalamine

Structural analogues of the active substance of the drug Retinalamin does not.

Analogues for the pharmacological group (regenerants and reparants):

• Actovegin;
• Apilak;
• Aurobin;
• Bezornil;
• Bepanten;
• Vinilin (Shostakovsky's Balm);
• Hepatrombin;
• Hyposol;
• D Panthenol;
• Dalargin;
• Dexpanthenol;
• Depanthol;
• Healthy eyes;
• Intragel;
• Kontraktubeks;
• Korneregel;
• Methyluracil;
• Sodium deoxyribonucleate;
• Okovidit;
• Olesesin;
• Paylex;
• Panagen;
• Panthenol;
• Pantoderm;
• Pentoxyl;
• Polyvinox;
• Relief Ultra;
• Reparff;
• Rumalon;
• Solcoseryl;
• Stellanin;
• Strix;
• Ulzep;
• Fitostimulin;
• Fusimet;
• Ebermin;
• Eberprot P;
• Eplan;
• The index.

Similar medicines:

Other medicines: